Search Results 471-480 of 16963 for monoclonal antibody
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...
Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Acalabrutinib may stop the growth of cancer ...
Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19). Obstet Gynecol 2022 Apr 1; 139 (4):616 ...
Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...
And the other is you mentioned monoclonal antibodies not to being effective. Are we still using them? Dr. Greg Poland 09:14. We are because there's some ...
... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Shah SZ, Alvarez FG, Sanghavi ...
Vaccination should be delayed by 90 days for their children who received monoclonal antibody or convalescent plasma or were given the diagnosis of COVID-19 — ...
Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the body's immune system attack the cancer and may interfere with the ...
The first calcitonin gene-related peptide monoclonal antibody to prevent migraine was approved in 2018. Today, four drugs have been approved: Eptinezumab ...
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.